Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11958849 GLS1 inhibitors for treating disease

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 17 Apr, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 17 Apr, 2024
Edits made to:
Infobox (+56 properties)
‌

 US Patent 11958849 GLS1 inhibitors for treating disease

Infobox
Is a
Patent
Patent
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
119588491
Patent Inventor Names
Anne Yau1
Barbara Czako1
Christopher Lawrence Carroll1
Gang Liu1
Jason P. Burke1
Jay Theroff1
Kang Le1
Maria Emilia Di Francesco1
Matthew M. Hamilton1
Michael J. Soth1
Philip Jones1
Richard Lewis1
Timothy Heffernan1
Timothy McAfoos1
Wylie S. Palmer1
Zachary Herrera1
Zhijun Kang1
Date of Patent
April 16, 2024
1
Patent Application Number
176605411
Date Filed
April 25, 2022
1
Patent Citations
‌
US Patent 7956070 Piperidines as chemokine modulators (CCR)
1
‌
US Patent 7985548 Materials and methods directed to asparagine synthetase and asparaginase therapies
1
‌
US Patent 9809588 GLS1 inhibitors for treating disease
1
‌
US Patent 10125128 GLS1 inhibitors for treating disease
1
‌
US Patent 10150753 Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
1
‌
US Patent 10344025 GLS1 inhibitors for treating disease
1
‌
US Patent 10722487 Glutaminase inhibitor therapy
1
‌
US Patent 10738043 GLS1 inhibitors for treating disease
1
‌
US Patent 10766892 GLS1 inhibitors for treating disease
1
‌
US Patent 10899740 Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
1
‌
US Patent 11045443 Glutaminase inhibitor therapy
1
‌
US Patent 11370786 GLS1 inhibitors for treating disease
1
‌
US Patent 11603365 Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide
1
‌
US Patent 11713313 GLS1 inhibitors for treating disease
1
Patent Primary Examiner
‌
John M Mauro
1
CPC Code
‌
C07D 417/14
1
‌
C07D 417/06
1
‌
C07D 405/14
1
‌
C07D 403/14
1
‌
C07D 403/06
1
‌
C07D 401/14
1
‌
C07D 493/08
1
‌
A61K 45/06
1
‌
A61P 35/00
1
‌
A61P 3/00
1
‌
A61P 25/00
1
‌
A61K 31/501
1
‌
A61K 31/497
1
‌
A61K 31/454
1
‌
A61K 31/444
1
‌
A61K 31/4439
1
‌
A61K 31/433
1
‌
A61K 31/4192
1

Find more entities like US Patent 11958849 GLS1 inhibitors for treating disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo